Motley Fool41d agobearish
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropSpecializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
526last 24h
2504last 7d
477● bullish (7d)
253● bearish (7d)
197publishers
Zacks91d agobearish
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallTransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
Zacks91d agobearish
TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesTransMedics (TMDX) delivered earnings and revenue surprises of -51.46% and -0.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?